Libre, Lance T.

HRN: 20-91-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/08/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
12/08/2022
12/14/2022
PO
2 Ml
Q 12
URTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: